Cambridge Cognition (LON:COG) Issues Earnings Results

Cambridge Cognition (LON:COGGet Free Report) released its quarterly earnings data on Wednesday. The company reported GBX (1.60) EPS for the quarter, Digital Look Earnings reports. Cambridge Cognition had a negative net margin of 17.82% and a negative return on equity of 62.89%.

Cambridge Cognition Stock Performance

Shares of COG traded down GBX 0.55 during midday trading on Wednesday, reaching GBX 27.45. 16,373 shares of the stock were exchanged, compared to its average volume of 33,138. The stock’s 50 day simple moving average is GBX 31.87 and its 200 day simple moving average is GBX 34.95. The company has a market cap of £14.81 million, a P/E ratio of -7.04 and a beta of 0.81. Cambridge Cognition has a twelve month low of GBX 26.60 and a twelve month high of GBX 45. The company has a quick ratio of 0.96, a current ratio of 0.40 and a debt-to-equity ratio of 29.16.

About Cambridge Cognition

(Get Free Report)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.

See Also

Earnings History for Cambridge Cognition (LON:COG)

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.